Several studies have demonstrated that HA during WBRT with or without memantine or donepezil (acetylcholinesterase selective inhibitor) can effectively reduce the risk of cognitive decline in patients without compromising tumor control [79–82]. The gene discussed is ACHE; the disease is neoplasm.